Personalised cancer vaccines show early signs of promise in trial
by Ian Sample, science editor from on (#6A8W)
Custom-made vaccines, designed to a make patient's immune system attack tumours, have been used in a small-scale patient trial with some success
Personalised cancer vaccines that target people's individual tumours have shown early signs of promise in tests on three patients diagnosed with advanced skin cancer.
The vaccines were designed to make the patients' immune systems unleash attacks on specific DNA mutations in their tumours, and so turn the body's natural defences against the disease.
